Champix® (varenicline tartrate) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Key opinion leaders discuss the medicalisation of smoking, the changing environment in the UK, tools required to support patients through smoking cessation and the role of pharmacotherapy
Hosted by Noel Baxter, GP and clinical commissioner for NHS Southwark and chair elect for the Primary Care Respiratory Society UK (PCRS-UK).
Matthew Evison - Consultant in Respiratory Medicine, Greater Manchester
Gareth Jones - Consultant Respiratory Physician, Royal Liverpool University Hospital
Is tobacco addiction a disease? Matthew Evison explains the burden of this disease in the UK.
Gareth Jones explains how the smoking cessation landscape has changed and the impact hospitals can have on patients' health by supporting them to quit.
Matthew Evison explains what you need to support patients through smoking cessation in a hospital setting including the right pathways and systems.
Matthew and Gareth explain the NICE evidenced treatment options for hospital patients.
Learn more about how using Very Brief Advice (VBA) and Brief Support and Treatment (BST) can help a smoker gain the motivation and support needed, to quit successfully.
Read about how Champix compares to nicotine replacement therapies.
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020